Literature DB >> 8174872

[Recurrent ventricular fibrillation, right bundle-branch block and persistent ST segment elevation in V1-V3: a new arrhythmia syndrome? A clinical case report].

A Proclemer1, D Facchin, G A Feruglio, R Nucifora.   

Abstract

In this report we describe a patient with a rare arrhythmic syndrome, recently reported and characterized by aborted sudden death, right bundle branch block and persistent ST segment elevation in precordial leads. The patient is a 65-year-old man, who had survived recurrent episodes of ventricular fibrillation (VF). The ECG during sinus rhythm revealed the coexistence of right bundle branch block and persistent ST segment elevation (1-4 mm) in leads V1-V3. The clinical and laboratory investigations, including echocardiography, cardiac catheterization and right endomyocardial biopsy, could not identify any significant morphological and functional cardiac abnormalities. The presence of late potentials (high gain ECG), and the inducibility of VF during the electrophysiological study, suggest a functional reentry as arrhythmogenic substratum. During a 60-month follow-up period, high-dose amiodarone per os, and subsequent AICD therapy successfully treated recurrent VF episodes. This clinical case confirms the existence of a new idiopathic malignant arrhythmic syndrome. Aggressive antiarrhythmic therapy seems fundamental in this type of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174872

Source DB:  PubMed          Journal:  G Ital Cardiol        ISSN: 0046-5968


  8 in total

1.  Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.

Authors:  Markéta Bébarová; Tom O'Hara; Jan L M C Geelen; Roselie J Jongbloed; Carl Timmermans; Yvonne H Arens; Luz-Maria Rodriguez; Yoram Rudy; Paul G A Volders
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 2.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 3.  Brugada syndrome: from cell to bedside.

Authors:  Charles Antzelevitch; Pedro Brugada; Josep Brugada; Ramon Brugada
Journal:  Curr Probl Cardiol       Date:  2005-01       Impact factor: 5.200

Review 4.  Therapy for the Brugada syndrome.

Authors:  C Antzelevitch; J M Fish
Journal:  Handb Exp Pharmacol       Date:  2006

Review 5.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

6.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.

Authors:  Pietro Delise; Giuseppe Allocca; Elena Marras; Carla Giustetto; Fiorenzo Gaita; Luigi Sciarra; Leonardo Calo; Alessandro Proclemer; Marta Marziali; Luca Rebellato; Giuseppe Berton; Leonardo Coro; Nadir Sitta
Journal:  Eur Heart J       Date:  2010-10-26       Impact factor: 29.983

7.  Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options.

Authors:  P Maury; M Hocini; M Haïssaguerre
Journal:  Indian Pacing Electrophysiol J       Date:  2005-01-01

8.  Brugada disease: chronology of discovery and paternity. Preliminary observations and historical aspects.

Authors:  Andres Ricardo Perez Riera; Edgardo Schapachnik; Celso Ferreira
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.